In vitro-in vivo study of CoQ10-loaded lipid nanoparticles in comparison with nanocrystals

International Journal of Pharmaceutics

Volumn 419, Issue 1-2, 2011, Pages 255-259

  Piao, Hongyu ^a   Ouyang, Mei ^a   Xia, Dengning ^a   Quan, Peng ^a   Xiao, Wenhua ^a   Song, Yanzhi ^a   Cui, Fude ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Bioavailability; CoQ10; Dissolution; Lipid nanoparticles; Nanocrystals; Sucrose monolaurate; Witepsol W35

Indexed keywords

LIPID NANOPARTICLE; MEDIUM CHAIN TRIACYLGLYCEROL; NANOCRYSTAL; NANOPARTICLE; UBIDECARENONE; UNCLASSIFIED DRUG; WITEPSOL W 35;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; IN VIVO STUDY; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUSPENSION; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ANIMALS; EXCIPIENTS; LIPIDS; MALE; NANOPARTICLES; PARTICLE SIZE; RATS; RATS, WISTAR; SOLUBILITY; SUCROSE; TRIGLYCERIDES; UBIQUINONE;

EID: 81155160978     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.07.016     Document Type: Article

References (23)

1. P. Balakrishnan, B.-J. Lee, D.H. Oh, J.O. Kim, Y.-I. Lee, D.-D. Kim, J.-P. Jee, Y.-B. Lee, J.S. Woo, and C.S. Yong Enhanced oral bioavailability of coenzyme Q10 by self-emulsifying drug delivery systems Int. J. Pharm. 374 2009 66 72
2. M.F. Beal Oxidatively modified proteins in aging and disease Free Radic. Biol. Med. 32 2002 797 803 (Pubitemid 34439250)
3. R. Belardinelli, A. Mucaj, F. Lacalaprice, M. Solenghi, G. Seddaiu, F. Principi, L. Tiano, and G.P. Littarru Coenzyme Q10 and exercise training in chronic heart failure Eur. Heart J. 27 2006 2675 2681 (Pubitemid 44729868)
4. H.N. Bhagavan, R.K. Chopra, N.E. Craft, C. Chitchumroonchokchai, and M.L. Failla Assessment of coenzyme Q10 absorption using an in vitro digestion-Caco-2 cell model Int. J. Pharm. 333 2007 112 117 (Pubitemid 46283277)
5. K.H. Bhandari, M. Newa, J.A. Kim, B.K. Yoo, J.S. Woo, W.S. Lyoo, H.T. Lim, H.G. Choi, and C.S. Yong Preparation, characterization and evaluation of coenzyme Q10 binary solid dispersions for enhanced solubility and dissolution Biol. Pharm. Bull. 30 2007 1171 1176 (Pubitemid 46883888)
6. S. Chakraborty, D. Shukla, B. Mishra, and S. Singh Lipid - an emerging platform for oral delivery of drugs with poor bioavailability Eur. J. Pharm. Biopharm. 73 2009 1 15
7. L. Ernster, and G. Dallner Biochemical, physiological and medical aspects of ubiquinone function Biochim. Biophys. Acta 1271 1995 195 204
8. J. Hecq, M. Deleers, D. Fanara, H. Vranckx, and K. Amighi Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine Int. J. Pharm. 299 2005 167 177 (Pubitemid 40962418)
9. C. Keck, and R. Muller Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation Eur. J. Pharm. Biopharm. 62 2006 3 16 (Pubitemid 41736019)
10. P.H. Langsjoen, and A.M. Langsjoen Overview of the use of CoQ10 in cardiovascular disease Biofactors 9 1999 273 284 (Pubitemid 29289007)
11. W. Mehnert Solid lipid nanoparticles: production, characterization and applications Adv. Drug Deliv. Rev. 47 2001 165 196 (Pubitemid 32324113)
12. S. Nazzal, N. Guven, I.K. Reddy, and M.A. Khan Preparation and characterization of coenzyme Q10-Eudragit solid dispersion Drug Dev. Ind. Pharm. 28 2002 49 57 (Pubitemid 34274559)
13. P.R. Nepal, H.-K. Han, and H.-K. Choi Enhancement of solubility and dissolution of coenzyme Q10 using solid dispersion formulation Int. J. Pharm. 383 2010 147 153
14. ®H35 based self-nanoemulsifying drug delivery systems (SNEDDS) of coenzyme Q10 Eur. J. Pharm. Sci. 39 2010 224 232
15. S. Pepe, S. Marasco, S. Haas, F. Sheeran, H. Krum, and F. Rosenfeldt Coenzyme Q10 in cardiovascular disease Mitochondrion 7 2007 S154 S167
16. C.J.H. Porter, N.L. Trevaskis, and W.N. Charman Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs Nat. Rev. Drug Discov. 6 2007 231 248 (Pubitemid 46344627)
17. T.D. Rozen, M.L. Oshinsky, C.A. Gebeline, K.C. Bradley, W.B. Young, A.L. Shechter, and S.D. Silberstein Open label trial of coenzyme Q10 as a migraine preventive Cephalalgia 22 2002 137 141 (Pubitemid 34494135)
18. K. Sakano, M. Takahashi, M. Kitano, T. Sugimura, and K. Wakabayashi Suppression of azoxymethane-induced colonic premalignant lesion formation by coenzyme Q10 in rats Asian Pac. J. Cancer Prev. 7 2006 599 603
19. C.W. Shults Coenzyme Q10 in neurodegenerative diseases Curr. Med. Chem. 10 2003 1917 1921
20. P.W. Stott, A.C. Williams, and B.W. Barry Mechanistic study into the enhanced transdermal permeation of a model beta-blocker, propranolol, by fatty acids: a melting point depression effect Int. J. Pharm. 219 2001 161 176 (Pubitemid 32391375)
21. V. Teeranachaideekul, E.B. Souto, V.B. Junyaprasert, and R.H. Müller Cetyl palmitate-based NLC for topical delivery of Coenzyme Q10-Development, physicochemical characterization and in vitro release studies Eur. J. Pharm. Biopharm. 67 2007 141 148 (Pubitemid 46991336)
22. K. Westesen Novel lipid-based colloidal dispersions as potential drug administration systems-expectations and reality Colloid Polym. Sci. 278 2000 608 618 (Pubitemid 30458731)
23. S.A. Wissing, O. Kayser, and R.H. Muller Solid lipid nanoparticles for parenteral drug delivery Adv. Drug Deliv. Rev. 56 2004 1257 1272 (Pubitemid 38510473)